设为首页 加入收藏 网站地图  
已发表的论文

浏览模式选择有摘要 无摘要 最简约
 
        
[1]. Chen Y, Qin MY, Wu JH, Wang L, Chao H, Ji LN, Xu AL. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex. Eur J Med Chem. 2013, 70: 120-129. [ IF( 2013 ): 3.432]
        
[2]. Chen Y, Qin MY, Wang L, Chao H, Ji LN, Xu AL. A ruthenium(II) β-carboline complex induced p53-mediated apoptosis in cancer cells. Biochimie. 2013, 95(11): 2050-2059. [ IF( 2013 ): 3.123]
        
[3]. Tan C, Wu S, Lai S, Wang M, Chen Y, Zhou L, Zhu Y, Lian W, Peng W, Ji L, Xu A*. Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes. Dalton Trans. 2011, 40(34): 8611-8621. [ IF( 2011 ): 3.838]
        
[4]. Tan C, Lai S, Wu S, Hu S, Zhou L, Chen Y, Wang M, Zhu Y, Lian W, Peng W, Ji L, Xu A*. Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis. J Med Chem. 2010, 53(21): 7613-7624. [ IF( 2010 ): 5.207]
        
[5]. Guan H, Chen H, Peng W, Ma Y, Cao R, Liu X, Xu A*. Design of beta-carboline derivatives as DNA-targeting antitumor agents. Eur J Med Chem. 2006, 41(10): 1167-1179.
        
[6]. Cao R, Peng W, Chen H, Hou X, Guan H, Chen Q, Ma Y, Xu A*. Synthesis and in vitro cytotoxic evaluation of 1,3-bisubstituted and 1,3,9-trisubstituted beta-carboline derivatives. Eur J Med Chem. 2005, 40(3): 249-257.
        
[7]. Hou XR, Chen Q, Cao RH, Peng WL, Xu AL*. A comparative molecular field analysis of cytotoxic beta-carboline analogs. Acta Pharmacol Sin. 2004, 25(7): 959-965.
        
[8]. Zhang N, Xu B, Mou C, Yang W, Wei J, Lu L, Zhu J, Du J, Wu X, Ye L, Fu Z, Lu Y, Lin J, Sun Z, Su J, Dong M, Xu A*. Molecular profile of the unique species of traditional Chinese medicine, Chinese seahorse (Hippocampus kuda Bleeker). FEBS Lett. 2003, 550(1-3): 124-134.
        
[9]. Cao R, Peng W, Chen H, Ma Y, Liu X, Hou X, Guan H, Xu A*. DNA binding properties of 9-substituted harmine derivatives. Biochem Biophys Res Commun. 2005, 338(3): 1557-1563.
        
[10]. Chen Q, Chao R, Chen H, Hou X, Yan H, Zhou S, Peng W, Xu A*. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer. 2005, 114(5): 675-682.

首页 上一页  下一页  尾页   页次:1/2页  共16条记录 10条记录/页 转到:
关键词:

中山大学医药分子实验室版权所有, 地址: 广东省广州市番禹区大学城中山大学生命科学院
电子邮件:lssxal@mail.sysu.edu.cn, 电话:86-020-39332990,传真: 86-020-39332950,邮编:510006

1023654